Thus, in the present study, we sought to investigate the profile of ER, PR, Ki67, and HER2 expression in primary breast tumors and synchronous ALN metastases in a series of preoperative bioptic samples, underlining relevant differences that are able to influence NAC, post-operative adjuvant strategies, and biological behavior. This evidence concerns the gene ERBB2 and breast neoplasm.